Juan Cosín Sales

Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity

Pilar Martín, B. Ibáñez, J. Cosín Sales, 2023, Clinical and Translational Oncology.

Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias.

L. Pérez de Isla, A. Castro Conde, F. Arribas Ynsaurriaga, 2017, Revista espanola de cardiologia.

Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

J. Cosín Sales, V. Barrios, J. Rivera‐Caravaca, 2022, European journal of clinical investigation.

Have the Government's prescription algorithm and the 2013 American College of Cardiology/American Heart Association guidelines for managing dyslipidemia influenced the management of dyslipidemia? The MEJORALO-CV Project

V. Fuster, C. Morillas Ariño, P. M. Blasco, 2020 .